Neo Ivy Capital Management - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$1,202
-95.5%
29,634
+3540.5%
0.81%
+1045.1%
Q3 2022$27,000
+107.7%
814
+313.2%
0.07%
+273.7%
Q4 2021$13,000
+116.7%
197
+173.6%
0.02%
+216.7%
Q2 2021$6,000
-62.5%
72
-80.7%
0.01%
-62.5%
Q3 2020$16,000
+433.3%
373
+191.4%
0.02%
+1500.0%
Q2 2020$3,000
-78.6%
128
-41.3%
0.00%
-93.8%
Q4 2019$14,000
+366.7%
218
+70.3%
0.02%
+700.0%
Q2 2019$3,0001280.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders